<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The use of <z:chebi fb="0" ids="50663">zanamivir</z:chebi> in seven patients with <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> (three A and four B) post allograft is described </plain></SENT>
<SENT sid="1" pm="."><plain>Inhaled <z:chebi fb="0" ids="50663">zanamivir</z:chebi> (10 mg twice daily) was continued from the diagnosis of <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> until excretion of virus ceased (median duration 15 days, range 5 to 44 days) </plain></SENT>
<SENT sid="2" pm="."><plain>There was no toxicity attributable to <z:chebi fb="0" ids="50663">zanamivir</z:chebi> and rapid resolution of <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> symptoms was seen </plain></SENT>
<SENT sid="3" pm="."><plain>There was no mortality due to <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> in the seven patients </plain></SENT>
<SENT sid="4" pm="."><plain>The good outcome of 30 previous patients with <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e> post transplant is described </plain></SENT>
<SENT sid="5" pm="."><plain>A randomised multicentre study would be required to demonstrate efficacy </plain></SENT>
</text></document>